These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21527506)

  • 21. Endobronchial ultrasound-guided transbronchial needle aspiration for differentiating N0 versus N1 lung cancer.
    Yasufuku K; Nakajima T; Waddell T; Keshavjee S; Yoshino I
    Ann Thorac Surg; 2013 Nov; 96(5):1756-60. PubMed ID: 23953728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients.
    Navani N; Brown JM; Nankivell M; Woolhouse I; Harrison RN; Jeebun V; Munavvar M; Ng BJ; Rassl DM; Falzon M; Kocjan G; Rintoul RC; Nicholson AG; Janes SM
    Am J Respir Crit Care Med; 2012 Jun; 185(12):1316-22. PubMed ID: 22505743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients.
    Ulivi P; Romagnoli M; Chiadini E; Casoni GL; Capelli L; Gurioli C; Zoli W; Saragoni L; Dubini A; Tesei A; Amadori D; Poletti V
    Int J Oncol; 2012 Jul; 41(1):147-52. PubMed ID: 22504767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of endobronchial ultrasound-guided transbronchial needle aspiration in lung cancer: importance of the lymph node involvement prevalence].
    De Dominicis F; Fourdrain A; Iquille J; Toublanc B; François G; Basille D; Monconduit J; Merlusca G; Jounieaux V; Andrejak C; Berna P
    Rev Pneumol Clin; 2015 Aug; 71(4):217-25. PubMed ID: 25727662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.
    Yasufuku K; Pierre A; Darling G; de Perrot M; Waddell T; Johnston M; da Cunha Santos G; Geddie W; Boerner S; Le LW; Keshavjee S
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1393-400.e1. PubMed ID: 21963329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of endobronchial ultrasound-guided transbronchial needle aspiration of hilar lymph nodes for diagnosing and staging cancer.
    Ernst A; Eberhardt R; Krasnik M; Herth FJ
    J Thorac Oncol; 2009 Aug; 4(8):947-50. PubMed ID: 19590457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of mediastinal staging with endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer.
    Ømark Petersen H; Eckardt J; Hakami A; Olsen KE; Jørgensen OD
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):465-8. PubMed ID: 19502074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging.
    Rintoul RC; Skwarski KM; Murchison JT; Wallace WA; Walker WS; Penman ID
    Eur Respir J; 2005 Mar; 25(3):416-21. PubMed ID: 15738283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates.
    Schuurbiers OC; Looijen-Salamon MG; Ligtenberg MJ; van der Heijden HF
    J Thorac Oncol; 2010 Oct; 5(10):1664-7. PubMed ID: 20871266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation.
    Han SW; Kim TY; Jeon YK; Hwang PG; Im SA; Lee KH; Kim JH; Kim DW; Heo DS; Kim NK; Chung DH; Bang YJ
    Clin Cancer Res; 2006 Apr; 12(8):2538-44. PubMed ID: 16638863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How I do it--optimal methodology for multidirectional analysis of endobronchial ultrasound-guided transbronchial needle aspiration samples.
    Nakajima T; Yasufuku K
    J Thorac Oncol; 2011 Jan; 6(1):203-6. PubMed ID: 21178716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endobronchial ultrasound guided transbronchial needle aspiration.
    Medford AR; Bennett JA; Free CM; Agrawal S
    Postgrad Med J; 2010 Feb; 86(1012):106-15. PubMed ID: 20145060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mRNA and miRNA analyses in cytologically positive endobronchial ultrasound-guided transbronchial needle aspiration: implications for molecular staging in lung cancer patients.
    Plönes T; Elze M; Kayser G; Pfeifer D; Burger M; Zissel G
    Cancer Cytopathol; 2014 Apr; 122(4):292-8. PubMed ID: 24574164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
    Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
    Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer.
    Shih JY; Gow CH; Yu CJ; Yang CH; Chang YL; Tsai MF; Hsu YC; Chen KY; Su WP; Yang PC
    Int J Cancer; 2006 Feb; 118(4):963-9. PubMed ID: 16152581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer.
    Shingyoji M; Nakajima T; Yoshino M; Yoshida Y; Ashinuma H; Itakura M; Tatsumi K; Iizasa T
    Ann Thorac Surg; 2014 Nov; 98(5):1762-7. PubMed ID: 25149044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer.
    Park S; Holmes-Tisch AJ; Cho EY; Shim YM; Kim J; Kim HS; Lee J; Park YH; Ahn JS; Park K; Jänne PA; Ahn MJ
    J Thorac Oncol; 2009 Jul; 4(7):809-15. PubMed ID: 19487967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer.
    Yasufuku K; Nakajima T; Motoori K; Sekine Y; Shibuya K; Hiroshima K; Fujisawa T
    Chest; 2006 Sep; 130(3):710-8. PubMed ID: 16963667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired resistance to gefitinib: the contribution of mechanisms other than the T790M, MET, and HGF status.
    Onitsuka T; Uramoto H; Nose N; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
    Lung Cancer; 2010 May; 68(2):198-203. PubMed ID: 19589612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer.
    Herth FJ; Eberhardt R; Krasnik M; Ernst A
    Chest; 2008 Apr; 133(4):887-91. PubMed ID: 18263680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.